Meihua Biological: Some directors, senior executives, and core management have completed additional purchases, with a total increase accounting for 1.142% of the total share capital.

robot
Abstract generation in progress
Meihua Biological Announcement: A total of 76 members, including some directors, senior management, and other core management (or technical backbones), based on their confidence in the company’s future development prospects and their recognition of the value of long-term investment, plan to increase their holdings of the company’s shares within 12 months starting from January 14, 2026, using their own funds or borrowed/raised funds. The planned total amount to increase holdings is not less than RMB 304 million and not more than RMB 350 million. As of June 8, 2026, the above-mentioned entities have cumulatively increased their holdings of 32.0184 million shares of the company through centralized bidding transactions in the secondary market, accounting for 1.142% of the company’s total share capital. The cumulative amount for the increased holdings is RMB 316 million, which has exceeded the lower limit of this increase plan. This increase plan has been fully implemented.
View Original
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pinned